{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:42:01Z","timestamp":1777653721271,"version":"3.51.4"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.1542\/hpeds.2022-006940","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T08:13:49Z","timestamp":1674461629000},"page":"e34-e36","source":"Crossref","is-referenced-by-count":3,"title":["It Is Time for Pediatric Hospitalists to Treat Opioid Use Disorder"],"prefix":"10.1542","volume":"13","author":[{"given":"Deepa R.","family":"Camenga","sequence":"first","affiliation":[{"name":"aDepartments of Emergency Medicine & Pediatrics"},{"name":"bYale Program in Addiction Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Barelli","sequence":"additional","affiliation":[{"name":"bYale Program in Addiction Medicine, New Haven, Connecticut"},{"name":"cInternal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"2023112713584485200_b1","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2020 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"issue":"8","key":"2023112713584485200_b2","doi-asserted-by":"crossref","first-page":"e186558","DOI":"10.1001\/jamanetworkopen.2018.6558","article-title":"US national trends in pediatric deaths from prescription and illicit opioids, 1999-2016","volume":"1","author":"Gaither","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"14","key":"2023112713584485200_b3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"2023112713584485200_b4","doi-asserted-by":"crossref","first-page":"e2022006864","DOI":"10.1542\/hpeds.2022-006864","article-title":"A novel inpatient buprenorphine induction program for adolescents with opioid use disorder","volume":"13","author":"Trope","year":"2023","journal-title":"Hosp Pediatr"},{"key":"2023112713584485200_b5","volume-title":"TIP 63: Medications for Opioid Use Disorder. Fore Healthcare and Addiction Professionals, Policymakers, Patients and Families","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"issue":"9","key":"2023112713584485200_b6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"17","key":"2023112713584485200_b7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"2023112713584485200_b8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"2023112713584485200_b9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/add.13363","article-title":"A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults","volume":"111","author":"Marsch","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"2023112713584485200_b10","doi-asserted-by":"crossref","first-page":"e20161893","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-assisted treatment of adolescents with opioid use disorders","volume":"138","author":"Committee on Substance Use and Prevention","year":"2016","journal-title":"Pediatrics"},{"key":"2023112713584485200_b11","volume-title":"Engineering and Medicine. Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences","year":"2019"},{"issue":"11","key":"2023112713584485200_b12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2023112713584485200_b13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12788\/jhm.3591","article-title":"Hospital buprenorphine program for opioid use disorder is associated with increased inpatient and outpatient addiction treatment","volume":"16","author":"Christian","year":"2021","journal-title":"J Hosp Med"},{"issue":"8","key":"2023112713584485200_b14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2023112713584485200_b15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2165\/00003088-198308050-00004","article-title":"Clinical pharmacokinetics of fentanyl and its newer derivatives","volume":"8","author":"Mather","year":"1983","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2023112713584485200_b16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder","volume":"14","author":"Crotty","year":"2020","journal-title":"J Addict Med"},{"key":"2023112713584485200_b17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajem.2022.05.013","article-title":"Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting","volume":"58","author":"Spadaro","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"6","key":"2023112713584485200_b18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/15563650.2022.2032730","article-title":"Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl","volume":"60","author":"Spadaro","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"2023112713584485200_b19","first-page":"22439","article-title":"Practice guidelines for the administration of buprenorphine for treating opioid use disorder","author":"US Department of Health and Human Services","year":"2021","journal-title":"Fed Regist"},{"issue":"6","key":"2023112713584485200_b20","doi-asserted-by":"crossref","first-page":"e2021053458","DOI":"10.1542\/peds.2021-053458","article-title":"State-by-state variability in adolescent privacy laws","volume":"149","author":"Sharko","year":"2022","journal-title":"Pediatrics"},{"issue":"4","key":"2023112713584485200_b21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","article-title":"Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorder","volume":"67","author":"Alinsky","year":"2020","journal-title":"J Adolesc Health"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/13\/2\/e34\/1574535\/hpeds.2022-006940.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/13\/2\/e34\/1574535\/hpeds.2022-006940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T13:59:40Z","timestamp":1701093580000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/13\/2\/e34\/190496\/It-Is-Time-for-Pediatric-Hospitalists-to-Treat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,23]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2022-006940","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}